The antiviral drug remdesivir is supposed to stop SARS-CoV-2 from replicating, but a recent study published in the Lancet suggests it may not be working the way it is supposed to.
Category: pharma & healthcare
Use Of Value-Based Contracting For Pharmaceuticals Is Underwhelming
Ultimately, better alignment of price and value of health technologies and medical services is the main objective of any healthcare system. This can be achieved through multiple means, including value-based contracts and coverage with evidence developm…
Urging Caution On Remdesivir
While there is much excitement around the potential of remdesivir to treat Covid-19, the data to date is unclear as to how well the drug might work and the risk to patients who are given it.
